Global Artificial Intelligence (AI) in Biotechnology Market Size to Exceed USD 20.75 Billion By 2035 | CAGR of 18.8%
Category: HealthcareGlobal Artificial Intelligence (AI) in Biotechnology Market Size to Exceed USD 20.75 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Artificial Intelligence (AI) in Biotechnology Market Size is Expected to Grow from USD 3.12 Billion in 2024 to USD 20.75 Billion by 2035, at a CAGR of 18.8% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 237 pages with 99 Market data tables and figures & charts from the report on The "Global Artificial Intelligence (AI) in Biotechnology Market Size, Share, and COVID-19 Impact Analysis, By Component (Software, Hardware, and Services), By Application (Drug Discovery & Development, Clinical Trials & Optimization, Medical Imaging, Diagnostics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/artificial-intelligence-ai-in-biotechnology-market
The global artificial intelligence (AI) in biotechnology market involves the incorporation of AI with biotech processes to improve research, development, and production of biological products. Key applications include drug discovery, genomics, diagnostics, personalized medicine, and bioinformatics. AI enables rapid data analysis, molecular behavior prediction, and experiment optimization, boosting efficiency and innovation. Market growth is driven by rising investment in biotech and AI, the need for faster drug development, and the increasing volume of genomic and proteomic data. Advancements in machine learning, computing power, and algorithmic capabilities support sophisticated AI applications. Government initiatives, funding, and public-private partnerships further fuel expansion. Additionally, the growing demand for precision healthcare and personalized medicine accelerates AI adoption. Collaborations between biotech and AI companies are strengthening innovation pipelines, while global efforts to regulate and support AI in life sciences create a supportive environment. However, high costs, privacy concerns, skill shortages, system integration challenges, and regulations hinder AI adoption in biotechnology.
The software segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the component, the artificial intelligence (AI) in biotechnology market is divided into software, hardware, and services. Among these, the software segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Increased use by AI in drug discovery, genomics, and predictive modeling is shaping biotech innovation. Software such as Schrödinger's and AlphaFold improve R&D, whereas cloud-enabled AI facilitates scalable, high-capacity laboratory data analysis and simulation.
The drug discovery & development segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the artificial intelligence (AI) in biotechnology market is divided into drug discovery & development, clinical trials & optimization, medical imaging, diagnostics, and others. Among these, the drug discovery & development segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. AI is increasingly used for target identification, screening of compounds, and lead optimization. Generative AI is used by companies to design drugs, and machine learning is used to forecast efficacy, lowering R&D expense and shortening drug development timelines.
North America is expected to hold the majority share of the global artificial intelligence (AI) in biotechnology market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global artificial intelligence (AI) in biotechnology market during the forecast period. The AI biotech market is boosted by increasing focus on precision medicine, the application of machine learning to analyze data, and tailor treatments. Regulatory support in North America drives adoption, facilitating more accurate, efficient, and rapid drug development as AI technologies develop.
Asia Pacific is anticipated to grow at the fastest pace in the global artificial intelligence (AI) in biotechnology market during the forecast period. The increasing health investments and genomics developments fuel AI adoption in biotechnology, improving precision medicine, diagnostics, and drug discovery through effective government, research, and private sector coordination.
Major vendors in the global artificial intelligence (AI) in biotechnology market are NVIDIA, BenevolentAI, AstraZeneca, Illumina, Recursion Pharmaceuticals, Insilico Medicine, Abbott Laboratories, Biogen, Novartis AG, Bristol-Myers Squibb, Schrödinger Inc., SOPHiA GENETICS, Tempus, Gilead Sciences, Merck KGaA, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2025, NVIDIA announced partnerships to revolutionize healthcare by accelerating drug discovery, genomic research, and advanced services using agentic and generative AI. Collaborating with leaders like IQVIA, Illumina, and Mayo Clinic, NVIDIA’s technologies improve clinical trials, digital pathology, and AI-driven surgery and patient monitoring.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the artificial intelligence (AI) in biotechnology market based on the below-mentioned segments:
Global Artificial Intelligence (AI) in Biotechnology Market, By Component
- Software
- Hardware
- Services
Global Artificial Intelligence (AI) in Biotechnology Market, By Application
- Drug Discovery & Development
- Clinical Trials & Optimization
- Medical Imaging
- Diagnostics
- Others
Global Artificial Intelligence (AI) in Biotechnology Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?